These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828 [TBL] [Abstract][Full Text] [Related]
5. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury. Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051 [TBL] [Abstract][Full Text] [Related]
6. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways. Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007 [TBL] [Abstract][Full Text] [Related]
7. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction. Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093 [TBL] [Abstract][Full Text] [Related]
8. In vivo cardiac role of migfilin during experimental pressure overload. Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081 [TBL] [Abstract][Full Text] [Related]
9. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763 [TBL] [Abstract][Full Text] [Related]
10. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload. Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290 [TBL] [Abstract][Full Text] [Related]
11. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure. Li J; Yousefi K; Ding W; Singh J; Shehadeh LA Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726 [TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure. Kim SK; Biwer LA; Moss ME; Man JJ; Aronovitz MJ; Martin GL; Carrillo-Salinas FJ; Salvador AM; Alcaide P; Jaffe IZ Circ Heart Fail; 2021 Feb; 14(2):e007279. PubMed ID: 33517669 [TBL] [Abstract][Full Text] [Related]